Skip to content

Clinical trials

Phase 3 Adenocarcinoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 3 Country / region: Taiwan Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20102
20142
20163
20182
20191
20212
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Global Development, Inc.3
AstraZeneca2
Australasian Gastro-Intestinal Trials Group2
Eli Lilly and Company2
Abbott1
Ariad Pharmaceuticals1
Boehringer Ingelheim1
Celgene1
Daiichi Sankyo1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma19
Neoplasms8
Stomach Neoplasms6
Carcinoma5
Carcinoma, Non-Small-Cell Lung5
Digestive System Neoplasms5
Digestive System Diseases4
Neoplasm Metastasis4
Neoplasms by Site4
Carcinoma, Large Cell3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.